ENvue Medical Inc. (NASDAQ: FEED) announced it has resumed commercial shipments of its PainShield therapeutic ultrasound device from its new U.S. manufacturing facility in Tyler, Texas, marking the completion of a manufacturing transition previously disrupted during the transfer of operations from Israel.
The company said it began fulfilling open orders through Ultra Pain Products Inc., its exclusive U.S. distribution partner, as part of efforts to restore supply to its commercial channel.
PainShield is a wearable, non-invasive therapeutic ultrasound device designed for pain treatment. It delivers low-frequency, low-intensity ultrasound through a treatment patch and is available by prescription in the United States. The device is part of a product portfolio formerly associated with NanoVibronix, whose manufacturing operations ENvue undertook to relocate.
The resumption of shipments follows a manufacturing disruption that occurred during the transfer process. Research and development for the NanoVibronix product portfolio continues to be based at facilities in Tel Aviv and Nesher, Israel, though production now runs out of the Tyler, Texas plant where the company is headquartered.
"Restoring PainShield production and commercial shipments was an immediate priority for us following a manufacturing disruption," said Doron Besser, chief executive officer of ENvue. "With U.S. production now operational, we are shipping product against existing orders and restoring supply to our commercial channel."
